@bull bear I think that stock might list flat and show an upward surge at which point people will realize that they missed out and rush to buy. i expect the price to cross 850 in the first month itself.
my expectation from ERIS listing is like that of the Laurus Lab.
I had applied 4 lots - got 3 allotments, yet holding on to all three of them. in the whole noise around US-FDA across the whole pharma industry, Laurus was not impacted and has been a slow and study mover from 428 to approx 625 in about 6 months.
I am expecting a similar performance from Eris also, may not be a massive listing, but sure this will go in long accumulation from mutual funds and insurance co as this stock is insulated from the US-FDA.
Disclaimer - I have applied 4 lots and intend to retain all the allotments until about Rs 750-775 (25% listing gain in about 3 months or so). and my target to sell Laurus is still about 700! so holdin on to all lots there too!
349.2. jajo| Link| Bookmark|
June 23, 2017 2:28:42 PM
Top Contributor (300+ Posts, 200+ Likes)
I think there is vast difference between Laurus & Eris Business models. Laurus has superb R&D facilities with higher spent on it. As for Eris, I still think it is highly priced and avoided it. No regrets! Still holding 4 lots of Laurus since IPO will hold for 1 year with target of 750.
I am happy Eris has started to move today. I will review my position for selling around 750-775 level in coming few days, that would be clean 25% listing gain!
348. P M| Link| Bookmark|
June 23, 2017 1:25:55 PM
(1100+ Posts, 1100+ Likes)
Allotment on Tuesday 27-07-2017 (Due to holiday on Monday) Today is Basis of Allotment